Details for New Drug Application (NDA): 215503
✉ Email this page to a colleague
NDA 215503 describes LIRAGLUTIDE, which is a drug marketed by Hikma and is included in one NDA. It is available from two suppliers. Additional details are available on the LIRAGLUTIDE profile page.
The generic ingredient in LIRAGLUTIDE is liraglutide. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the liraglutide profile page.
The generic ingredient in LIRAGLUTIDE is liraglutide. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the liraglutide profile page.
Summary for 215503
| Tradename: | LIRAGLUTIDE |
| Applicant: | Hikma |
| Ingredient: | liraglutide |
| Patents: | 0 |
Pharmacology for NDA: 215503
| Mechanism of Action | Glucagon-like Peptide-1 (GLP-1) Agonists |
Suppliers and Packaging for NDA: 215503
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LIRAGLUTIDE | liraglutide | SOLUTION;SUBCUTANEOUS | 215503 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9144 | 0143-9144-02 | 2 SYRINGE, PLASTIC in 1 CARTON (0143-9144-02) / 3 mL in 1 SYRINGE, PLASTIC |
| LIRAGLUTIDE | liraglutide | SOLUTION;SUBCUTANEOUS | 215503 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9144 | 0143-9144-03 | 3 SYRINGE, PLASTIC in 1 CARTON (0143-9144-03) / 3 mL in 1 SYRINGE, PLASTIC |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;SUBCUTANEOUS | Strength | 18MG/3ML (6MG/ML) | ||||
| Approval Date: | Dec 23, 2024 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
